Form 4 for ICUI ICU MEDICAL INC/DE
Accepted 2026-03-09 00:00:00 ET · period of report 2026-03-07 · accession 0002013412-26-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-09 | 2026-03-07+ | ICUI | Sousa Ben | CIO | M - OptEx | $0.00 | +9,543 | 5,273 | New | $0 |
| DM | 2026-03-09 | 2026-03-07+ | ICUI | Sousa Ben | CIO | F - Tax | $132.00 | -5,278 | 4,744 | -53% | -$696.7K |
| DM | 2026-03-09 | 2026-03-07+ | ICUI | Sousa Ben | CIO | M - OptEx | $0.00 | -9,543 | 3,775 | -72% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-07 | M | A | 1,409 | $0.00 | 1,888 | D | — | — | (F1) These securities are Restricted Stock Units. |
| 2 | Common | Common Stock | 2026-03-07 | F | D | 782 | $132.00 | 1,106 | D | — | — | |
| 3 | Common | Common Stock | 2026-03-08 | M | A | 7,177 | $0.00 | 8,283 | D | — | — | (F2) Represents the settlement of performance stock units granted on 3/8/2024. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 250% of target, resulting in the acquisition of the shares reported herein. |
| 4 | Common | Common Stock | 2026-03-08 | F | D | 3,967 | $132.00 | 4,316 | D | — | — | |
| 5 | Common | Common Stock | 2026-03-08 | M | A | 957 | $0.00 | 5,273 | D | — | — | (F1) These securities are Restricted Stock Units. |
| 6 | Common | Common Stock | 2026-03-08 | F | D | 529 | $132.00 | 4,744 | D | — | — | |
| 7 | Derivative | Performance Shares | 2026-03-08 | M | D | 7,177 | $0.00 | 0 | D | $0.00 · 2026-03-08 to 2027-03-08 | 7,177 Common Stock | (F6) These Securities are Performance-based Restricted Stock Units (PRSU). (F2) Represents the settlement of performance stock units granted on 3/8/2024. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 250% of target, resulting in the acquisition of the shares reported herein. (F7) There is neither a purchase price nor an exercise price for the PRSUs. |
| 8 | Derivative | Common Stock | 2026-03-07 | M | D | 1,409 | $0.00 | 4,732 | D | — · 2026-03-07 to — | 1,409 Common Stock | (F1) These securities are Restricted Stock Units. (F3) There is neither a purchase price nor an exercise price for the Restricted Stock Units. (F4) One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. (F5) These are restricted stock units that fully vest 3 years from the grant date. |
| 9 | Derivative | Common Stock | 2026-03-08 | M | D | 957 | $0.00 | 3,775 | D | — · 2026-03-07 to — | 957 Common Stock | (F1) These securities are Restricted Stock Units. (F3) There is neither a purchase price nor an exercise price for the Restricted Stock Units. (F4) One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. (F5) These are restricted stock units that fully vest 3 years from the grant date. |